Latest News for: aacr

Edit

Akari Therapeutics Appoints Former AACR President and Renowned Oncology Drug Development Leader, Patricia LoRusso, D.O., ...

Nasdaq Globe Newswire 07 Jul 2026
Globally recognized leader in early-phase oncology clinical development and experimental therapeutics ... .
Edit

Debbie's Dream Foundation and AACR Announce Innovation and Discovery Grant to Advance Gastric Cancer Research

PR Newswire 11 Jun 2026
"In collaboration with AACR, we are proud to support ... Additional application details can be found at https.//www.aacr.org/grants/aacr-debbies-dream-foundation-innovation-and-discovery-grant/ .
Edit

CREATV BIO STUDIES PRESENTED AT AACR ANNUAL MEETING SHOWING IMPORTANCE OF MONITORING PD-L1, MITOTIC CTCs and CAMLs IN BLOOD

PR Newswire 20 May 2026
("Creatv"), a cancer diagnostic blood testing company, presented five posters in conjunction with several research collaborators at the 2026 AACR Annual Meeting, held in San Diego, CA. 1 ... Key Finding ... 2 ... Key Finding ... 3 ... Key Finding ... 4 ... Key Finding ... 5 ... 21% ... .
Edit

Jabez Biosciences Presents First-in-Human Pharmacokinetic and Pharmacodynamic Data for JBZ-001 at AACR Annual Meeting 2026

Nasdaq Globe Newswire 11 May 2026
Phase 1 Clinical Data Demonstrate Dose-Proportional PK, No Dose-Limiting Toxicities Through Four Dose Levels, and Concordance with Preclinical PBPK Predictions ... .
Edit

Diakonos Oncology Reports Positive Clinical Data from Phase 1 Pancreatic Cancer Study and Expanded Access Program in Glioblastoma at AACR and AAN 2026

PR Newswire 01 May 2026
"Presenting clinical data at both AACR and AAN underscores the breadth of the DOC1021 platform across multiple hard-to-treat cancers with significant unmet need," said Jay Hartenbach, President and Chief Operating Officer of Diakonos Oncology.
Edit

D3 Bio Presents KRAS Pipeline Updates at AACR 2026; Elisrasib (D3S-001), a Next-Generation KRAS G12C ...

Index-Journal 30 Apr 2026
Elisrasib monotherapy demonstrates notable efficacy in three major tumor types at its recommended phase 2 dose (RP2D, 600 mg QD). Phase 2 clinical outcomes include ....
Edit

WuXi AppTec Presents Oncology Drug Discovery Advances at AACR 2026

The Post and Courier 30 Apr 2026
... Association for Cancer Research (AACR), held April .
Edit

D3 Bio Presents KRAS Pipeline Updates at AACR 2026; Elisrasib (D3S-001), a Next-Generation KRAS G12C Inhibitor, Shows Strong Phase 2 Efficacy Across Multiple Tumor Types

PR Newswire 30 Apr 2026
Phase 2 data for elisrasib were shared as oral presentations at the American Association for Cancer Research (AACR) Annual Meeting 2026 during both the ... Additional D3 Bio Presentations at AACR 2026.
Edit

ACROBiosystems Showcases AI-Driven Innovation at AACR 2026, Empowering Next-Generation Biologics Discovery

The Galveston Daily News 28 Apr 2026
SAN DIEGO and NEWARK, N.J., April 28, 2026 /PRNewswire/ -- ...
Edit

CUHK Vice-Chancellor and President Professor Dennis Lo Yuk-ming awarded 2026 AACR-Irving Weinstein Foundation Distinguished Lectureship First Hong Kong scientist to receive the honour (The Chinese University of Hong Kong)

Public Technologies 24 Apr 2026
CUHK Vice-Chancellor and President Professor Dennis Lo Yuk-ming awarded 2026 AACR-Irving Weinstein Foundation Distinguished Lectureship ... "I am deeply honoured to receive this recognition and sincerely thank AACR for acknowledging my research.
Edit

AACR 2026: Roswell Park tests mechanism-based strategy for p53 cancers

The Buffalo News 23 Apr 2026
Roswell Park researchers present a two-step, mechanism-based drug strategy at AACR 2026 that selectively targets cancers with TP53 mutations now in clinical trial ....
Edit

AACR 2026 | Abbisko Therapeutics Showcases Six Research Advances Highlighting pan-KRAS, 4th Generation EGFR, and ...

Killeen Daily Herald 23 Apr 2026
SAN DIEGO, April 22, 2026 ....
Edit

Alligator Bioscience Comments on Henlius Presentation of HLX49 Preclinical Data at AACR 2026

Killeen Daily Herald 23 Apr 2026
LUND, SE / ACCESS Newswire / April 23, 2026 / Alligator Bioscience (Nasdaq Stockholm.ATORX) today announced that ....
Edit

Tonix Pharmaceuticals Presents Updates on Preclinical Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2026 (Form 8-K) (Tonix Pharmaceuticals Holding Corp)

Public Technologies 23 Apr 2026
at the American Association for Cancer Research (AACR) Annual Meeting 2026 ... at the American Association for Cancer Research (AACR) Annual Meeting 2026, held April 17-22, 2026, in San Diego, California.
Edit

Moleculin’s Annamycin Extends Survival by More Than 60% in Metastatic Pancreatic Cancer Preclinical Models - Data Presented at AACR 2026 (Form 8-K) (Moleculin Biotech Inc)

Public Technologies 23 Apr 2026
Moleculin's Annamycin Extends Survival by More Than 60% in Metastatic Pancreatic Cancer Preclinical Models - Data Presented at AACR 2026 ... These data were presented at the American Association for Cancer Research (AACR) Annual Meeting 2026.

Article Search

tools
×
×
×
×